Key themes in lung cancer at NACLC 2022

Highlights at NACLC 2022: biomarkers in lung cancer and immunotherapyПодробнее

The emerging role of localized therapy in metastatic NSCLCПодробнее

ASCO22 Lung Cancer Key Takeaways | Ravi Salgia, MD, PhD | 2022 Review and Renew SedonaПодробнее

NSCLC trial updates at ESMO 2022: ADAURA, DESTINY-Lung02, KN189, KN407 & POSEIDONПодробнее

Unanswered questions in treating NSCLC with radiotherapyПодробнее

Tumor mutation burden as a biomarker in NSCLCПодробнее

NGS key for optimal lung cancer treatmentПодробнее

Key Opinion Leader Dr. Ed Schuuring Discusses the Role of ddPCR in Lung Cancer ResearchПодробнее

Highlights in lung cancer at ESMO 2022Подробнее

Changes in the Field of Metastatic NSCLC - 2022 Program: Targeted Therapies Forum - EnglishПодробнее

Observing lung cancer progression with liquid biopsiesПодробнее

Lung Cancer Research Highlights From ASCO 2022Подробнее

The Latest Lung Cancer Research Updates From ASCO 2022Подробнее

Key findings from the 2019-2020 National Lung Cancer Audit reportПодробнее

Key Insights in Lung Cancer: from the 22nd Annual Perspectives in Thoracic OncologyПодробнее

Highlights from the IASLC 2022 World Conference on Lung Cancer congressПодробнее

Lung Cancer Video Library - Immunotherapy in Stage lll NSCLC - The Pacific Trial and ImfinziПодробнее